NSETrading Window5d ago · 1 Sept 2026, 04:20 pm
Trading Window
Symbiotec Pharmalab Limited · SYMBIOTEC
✦ AI Summary
Symbiotec Pharmalab Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern5/10
Regulatory Risk5/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Symbiotec Pharmalab Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
SYMBIOTEC_01092026162040_Trading_Window_Closure.pdf
View document text
Date: September 01, 2026
Sr. General Manager Sr. General Manager
Listing Department Listing Department
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Dalal Street, Exchange Plaza, C-1, Block G
Mumbai - 400001. Bandra -Kurla Complex, Bandra (East),
Mumbai- 400051.
Scrip Code: 544889 Scrip Symbol : SYMBIOTEC
ISIN: INE899I01028 ISIN: INE899I01028
Subject: Intimation of Closure of Trading Window pursuant to SEBI (Prohibition of Insider Trading)
Regulations, 2015
Dear Sir/Madam,
Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to
time, we wish to inform you that in terms of Company's Code of Conduct for Regulating, Monitoring and
Reporting of Trading by Insiders, the trading window for dealing in securities of the Company will remain
closed for all Designated Person and their immediate relatives from Tuesday, September 01, 2026 till 48
hours after the declaration of unaudited Financial Results of the Company for the quarter ended June 30,
2026.
The same is being informed to the designated person and connected person in accordance with the
Company’s Code of Conduct for Prohibition of Insider trading.
Further, the date of meeting of the Board of Directors of the Company to consider and approve the
unaudited Financial Results of the Company for the said period shall be informed in due course.
Kindly take the same on record.
Thanking You,
For SYMBIOTEC PHARMALAB LIMITED
Salil Jain
Company Secretary and Compliance Officer
Membership No. A41610
Registered Office & Works:
Symbiotec Pharmalab Limited
(Formerly known as Symbiotec Pharmalab Pvt. Ltd.)
385/2, Pigdamber, Rau, Mhow, Indore - 453331, Madhya Pradesh, India
Tel. No.: +91-731-6676405-406 Fax: +91-731-4201222,
Email ID : symbiotec@symbiotec.com, Website : www.symbiotec.com
CIN: U24232MP2002PLC015293